Study for the relieving effect of a subject sample on depression

Antidepressant pharmacodynamics test study of a subject sample

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025991

Enrollment

Unknown

Registered

2019-09-16

Start date

2019-09-17

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Experimental group:Intervention 3.2g/day, oral, three months

placebo:placebo 3.2g/day, oral, three months

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The cumulative score of each item in the Self-rating Depression Scale (SDS) is greater than or equal to 0.5; 2. Aged 18-35 years.

Exclusion criteria

Exclusion criteria: 1. Suffering from other mental disorders; 2. Alcohol dependence; 3. Severe neurological, thyroid, heart or kidney diseases; 4. History of head trauma; 5. Pregnancy or lactation; 6. History of taking any antidepressant.

Design outcomes

Primary

Measure	Time frame
Monoamine neurotransmitters;interleukin-6;gama-aminobutyric acid;brain-derived neurotrophic factor ;beta-endorphin;routine blood test;	—

Countries

China

Contacts

Public ContactGuowei Huang

School of Public Health, Tianjin Medical University

huangguowei@tmu.edu.cn+86 22 83336603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026